Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stopping TNF blockers in rheumatoid arthritis with stable low disease activity
NL-OMON22466Recruiting
- Sponsor
- NVR, Inc.
- Start
- Oct 2011
- Countries
- 1
01
Overview
Randomised, open-label trial in rheumatoid arthritis (RA) (2 arms), sponsored by NVR, Inc. Primary endpoint: Exacerbation of rheumatoid arthritis during the first year. Started Oct 2011; status: recruiting.
02
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON22466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22466.